Performance of composite measures used in a trial of etanercept and methotrexate as monotherapy or in combination in psoriatic arthritis

OBJECTIVES: To examine which composite measures are most sensitive to change when measuring psoriatic arthritis (PsA) disease activity, analyses compared the responsiveness of composite measures used in a 48-week randomized, controlled trial of MTX and etanercept in patients with PsA. METHODS: The t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Rheumatology (Oxford)
Main Authors: Coates, Laura C, Merola, Joseph F, Mease, Philip J, Ogdie, Alexis, Gladman, Dafna D, Strand, Vibeke, van Mens, Leonieke J J, Liu, Lyrica, Yen, Priscilla K, Collier, David H, Kricorian, Gregory, Chung, James B, Helliwell, Philip S
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Clinical Science
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7937022/
https://ncbi.nlm.nih.gov/pubmed/32864685
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/keaa271
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados